Antiviral Drugs Market to Clock US$82.9 bn by 2024, Rise in Number of FDA approval to Fuel Market’s Growth

1
Antiviral Drugs Market

• Antiviral Drugs Market Segmentation by Disease
  Indication - Hepatitis Virus Infection, HIV
  Infection, and Respiratory Virus Infection
  Product Type - Branded Drugs and Generic Drugs
  Distribution Channels - Hospital Pharmacy Store,
  Retail Pharmacy Store, and Online Pharmacy, and
  Forecast, 2016 - 2024

2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Global Antiviral Drugs Market Analysis and Forecasts, By Software Type
Chapter 6 Global Antiviral Drugs Market Analysis, by Modality
Chapter 7 Global Antiviral Drugs Market Analysis, by Application
Chapter 8 Global Antiviral Drugs Market Analysis, by End-user
Chapter 9 Global Antiviral Drugs Market Analysis and Forecast by Region
Chapter 10 Europe Antiviral Drugs Market Analysis and Forecast
Chapter 11 Asia Pacific Antiviral Drugs Market Analysis and Forecast
Chapter 12 Latin America Antiviral Drugs Market Analysis and Forecast
Chapter 13 Middle East Africa Antiviral Drugs Market Analysis and Forecast
Chapter 14 Competition Landscape

2019 Transparency Market Research, All Rights
Reserved
3
Antiviral Drugs Market - Snapshot

• Antiviral drugs refer to those prescription
  medicines that are capable of fighting against
  flu viruses in ones body.
• Antiviral drugs could include intravenous
  solutions, an inhaled powder, liquid, or pills.
• The global antiviral drugs market is likely to
  observe considerable growth due to the rising
  incidences of viral infections.
• As coronavirus spreads at an exponential rate and
  the number of deaths crosses 74,000 worldwide,
  efforts are being made to lessen transmission
  through standard public health interventions.
  These interventions are based on tracing of
  contacts and isolation of cases.
• So far, there is no drug or vaccine to contain
  the spread of the pandemic worldwide.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Reports Highlights

• The global antiviral drugs market will exhibit a
  healthy CAGR of 6.40 during the forecast period
  of 2016 to 2024.
• The global antiviral drugs market is projected to
  rise at a significant pace in the coming few
  years.
• Availability of strong product pipeline is
  another factor expected to propel the growth of
  the global antiviral drugs market in the coming
  years.
• As per a study, over 36 million people around
  the globe are suffering from HIV infection in
  2014. Further, the population in the region
  touched 2.0 million new cases of HIV.

2019 Transparency Market Research, All Rights
Reserved
6
Continue..

• Researchers and doctors have observed that
  antiviral drugs administered shortly after the
  onset of symptoms can diminish the infectiousness
  to others through diminished viral shredding in
  the patients respiratory secretions.
• Growing prevalence of viral diseases such as
  malaria, dengue, chikungunya, and other deadly
  viral diseases is prompting an ever increasing
  demand for these antiviral drugs from these
  regions.
• Some of the key players in the global antiviral
  drugs market include names such as Merck Co.
  Inc., Johnson and Johnson, Schering-Plough
  Corporation, AbbVie Inc., and AstraZeneca Plc.
  among others.

2019 Transparency Market Research, All Rights
Reserved
7
Contact

• To know more about us, please visit our website
• www.transparencymarketresearch.com
• For sales queries or new topics email us on
• sales_at_transparencymarketresearch.com
• Thank You

2019 Transparency Market Research, All Rights
Reserved